Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
25/03/2026 11:20
March 25 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A: APIMEDS PHARMACEUTICALS - APPOINTS YOUNGJIK CHO AS CHAIRMAN OF THE BOARD - SEC FILING APIMEDS PHARMACEUTICALS- ON MAR 20, REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONNELL, BENNETT WEINTRAUB AS DIRECTORS EFFECTIVE IMMEDIATELY - SEC FILING APIMEDS PHARMACEUTICALS US INC - REMOVES DR. VIN MENON AS CEO EFFECTIVE IMMEDIATELY - SEC FILING APIMEDS PHARMACEUTICALS US INC - APPOINTS YOUNGJIK CHO AS CEO AND JUNYOUNG YU AS SECRETARY EFFECTIVE IMMEDIATELY - SEC FILING Further company coverage: APUS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apimeds Pharmaceuticals US
See all newsBrief: Mindwave Innovations Signs 3 Client Network Agreements In 10 Days, Extending Mindchain Into Climate Finance, Sports Media And Insurance Apimeds Pharmaceuticals Us Provides Required NYSE American Disclosure
Brief: Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19
Brief: Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer
Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
Brief: Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc